Search Icon
SideMenu
Home
Reports

Biosimilars Council Press Releases

Reports
  • Reports

White Paper: Potential Savings from Accelerating U.S. Approval of Complex Generics
  • Reports

White Paper: Access Denied: Why New Generics Are Not Reaching America’s Seniors
  • Reports

The Unintended Economics of the BLOCKING Act
  • Reports

Medicare Part D Generic Drug Tiering Request for Comment: Implications for Patient Out-of-Pocket Spending and Part D Plan Costs
  • Reports

7 Policy Solutions
  • Reports

Report: 2019 Generic Drug & Biosimilars Access & Savings in the U.S.
  • Reports

2020 Generic Drug & Biosimilars Access and Savings in the U.S. Report
  • Reports

The USMCA Will Keep Drug Prices Out of Reach for Patients, But Congress Can Fix It
  • Reports

Biosimilars Handbook
  • Reports

Commitment to Quality Excellence
  • Reports

White Paper (Part 1) Failure to Launch: Patent Abuse Blocks Access to Biosimilars for America’s Patients
  • Reports

2018 Generic Drug Access and Savings Report
Load More
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington DC 20001
JOIN

Advocacy

About Us

Events

Resources

Sign-up for Update

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Subscribe

© 2025 Association for Accessible Medicines (AAM), All Rights Reserved
Privacy Policy  |  Terms of Use  |  Contact

Stay Connected

For the latest updates, follow us on social media.

Facebook-f X-twitter Linkedin-in Youtube Instagram